Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT06315114
Recruiting Not applicable

A Transdiagnostic Mentalization-based Intervention for Parents With Mental Disorders

NCT06315114 · tracked via the Priya Life Science Denmark tracker
Phase
Not applicable
Started
2024-03-11
Last updated
2025-05-14

Condition(s) studied

Mental DisorderBehavior DisordersDiagnosis, PsychiatricDiagnosis DualSevere Mental DisorderMental IllnessPsychiatric DisorderPsychiatric DiseasePsychiatric Illness

Investigational drug(s) / intervention(s)

Lighthouse MBT Parenting Program (LPP)Care as usual (CAU)

Lighthouse MBT Parenting Program (LPP): The experimental group is a manualized transdiagnostic mentalization-based parenting intervention (Lighthouse MBT Parenting Program). This is a 12-week parenting group intervention (weekly session of 2 hours) with one preperatory initial individual session (1 hour) before the group commence.

Care as usual (CAU): 1-2 next of kin sessions (called 'Familiesamtale') is considered the care as usual offered to parents in adult mental health service in the Capital Region of Denmark. Parents are offered the possibility of bringing their spouse or offspring to one of the sessions.

Study summary

The aim of this randomised clinical trial is to evaluate the short and longterm effects of a transdiagnostic mentalization-based intervention (Lighthouse MBT Parenting Program) compared to care as usal (CAU) for parents with a mental disorder in adult mental health service.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria exclusive to the Outpatient Clinic * Age \>18 years * Seeking treatment for one of the following non-psychotic disorders according to ICD-10: obsessive-compulsive disorder and anxiety disorders (F40-42), posttraumatic stress disorder (DF43), personality disorders (F60-61), or one of the previous disorders and a drug-or alcohol related disorder (F10-19) (i.e. 'dual diagnosis disorder') Inclusion Criteria exclusive to the trial: * Parent of at least one child aged 0-17 years of age at baseline * Fluent i.e., sufficient Danish language skills * Parent is living with child or is in regular contact (min. 5 days monthly) * Written informed consent Exclusion Criteria exclusive to the Outpatient Clinic: * Possibility of a learning disability (IQ\<75) * A diagnosis of schizotypal personality disorder or antisocial personality disorder * Presence of a comorbid psychiatric disorder that requires specialist treatment elsewhere * Concurrent psychotherapeutic treatment outside the clinic Exclusion Criteria exclusive to the trial: * Acute suicidal risk or state of crises * Lack of informed consent * Acute child endangerment * Participation in another parenting focused intervention simultaniously

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Psychotherapeutic Centre Stolpegaard Gentofte Municipality Capital Region Recruiting
Psychotherapeutic Centre Stolpegård Gentofte Municipality Denmark Recruiting

More Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital trials in Denmark

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06315114 on ClinicalTrials.gov ↗ ← All trials in Denmark